Anson Funds Management LP Summit Therapeutics Inc. Transaction History
Anson Funds Management LP
- $420 Million
- Q1 2025
Shares
1 transactions
Others Institutions Holding SMMT
# of Institutions
246Shares Held
87.3MCall Options Held
1.77MPut Options Held
2.49M-
Baker Bros. Advisors LP New York, NY24.4MShares$700 Million5.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.6MShares$334 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$226 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$188 Million0.02% of portfolio
-
State Street Corp Boston, MA4.85MShares$139 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $5.77B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...